SQNM is a stock whose sole fundamental credibility is on a prenatal test for Down Syndrome which showed results that outperformed its competition by an apparently wide margin. However, the stock is currently trading at a near $1b market cap on revenue of less than $50mm. Even if management is correct and the test works and changes the prenatal testing industry, the upward price momentum should stop in the short term as prior investors seek to take profits on their YTD gain of ~100%. In addition, the degree to which this stock has run and the volume supporting it suggest that we should see a consolidation shortly. Worth a short position with a minor option hedge, in my opinion.